Research Solutions 2027 Q1 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Fiscal 2027 first-quarter revenue was $11.9 million, compared with $12.3 million in the prior-year quarter, as increased platform revenue was more than offset by lower transaction revenue.
- Platform subscription revenue increased 3.7% to $5.3 million, while transaction revenue declined approximately 8% to approximately $6.6 million, primarily reflecting lower paid order volume.
- Total ARR was $22.5 million, up 5.7% year over year, including approximately $16.5 million of B2B ARR and approximately $6 million of normalized ARR associated with Cite's B2C subscribers.
- B2B ARR grew $1.7 million, or 11.5%, year over year; normalized B2C ARR declined approximately $299,000 during the quarter, while net B2B ARR increased approximately $257,000.
- AI-related ARR was approximately $1.1 million, up 38% from the end of fiscal 2026, and B2B AI-related sales were up 38% sequentially from Q4 FY26.
- The company added 22 net new platform deployments, bringing the quarter-end total to 1,298; active customers were 1,360, compared with 1,326 a year earlier.
- Consolidated gross margin increased 300 basis points year over year to 53.6%, and gross profit grew 2.5% to $6.4 million despite lower revenue.
- Platform gross margin was 87%, compared with 88.1% in the prior-year quarter; transaction gross margin was 26.7%, compared with 23.8% in the prior quarter.
- Net income was $765,000, or $0.02 per diluted share, compared with $749,000, or $0.02 per diluted share, in the prior-year quarter; adjusted EBITDA was $1 million, or an 8.6% margin, compared with $1.5 million.
- Operating cash flow was approximately $1.2 million, compared with approximately $1.1 million in the prior-year quarter; cash was $12.6 million at September 30th, 2026, with no long-term debt and no borrowings under the $500,000 revolving line of credit.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good morning, everyone, and thank you for participating in today's conference call to discuss Research Solutions' financial and operating results for its fiscal 2027 first quarter ended September 30, 2026. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. John Beisler, Investor Relations.
Please go ahead. Thank you, Leslie, and good morning, everyone.
Welcome to the Research Solutions first quarter fiscal year 2027 earnings call. With me today are Roy W. Olivier, Chairman and Chief Executive Officer, Dave Kutil, Chief Financial Officer, and Josh Nicholson, Chief Strategy Officer. After the market closed yesterday afternoon, the company issued a press release announcing its results for the first quarter of fiscal 2027. The release is available on the company's website at researchsolutions.com. Before management begins their prepared remarks, I would like to remind you that some of the statements made today will be forward-looking and made under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied due to a variety of factors.
We refer you to Research Solutions' recent filings with the SEC for a more detailed discussion of the risks that could impact the company's future operating results and financial condition. Also on today's call, management will reference certain non-GAAP financial measures, which we believe provide useful information for investors. A reconciliation of these measures to GAAP measures is included in the earnings press release issued yesterday afternoon. Finally, I would like to remind everyone that this call will be recorded and made available for replay via a link on the company's website. I would now like to turn the call over to Roy W. Olivier. Roy? Thank you, John.
As we continue to develop our next-generation AI-based research tools, we watch a few key metrics that ensure we're on track to that objective. We believe that publisher participation and customer adoption are two of the critical metrics, and we saw nice progress in Q1, offset by weakness in our B2C and DocDel business. While churn is not where we want it to be, we did see a slight improvement during Q1. Our B2B AI-related sales were up 38% sequentially from Q4 FY 2026. As reported last week, we closed a $1 million ARR deal last week and continue to see a number of five-figure, six-figure, and some seven-figure opportunities in our pipeline. We do have a stronger pipeline than at any time in the past. It's currently well over $5 million in ARR.
In my mind, these early indicators reinforce that we're on the right path. We did launch an MCP for Copilot, supporting both Scite and Article Galaxy functionality. A researcher can interact with any supported LLM, then ask that LLM to go get those documents, and Article Galaxy will go get them in a copyright-compliant way. We're continuing to see strong adoption and interest of the previously released Claude, Enterprise, and ChatGPT solutions. As noted in our release, we continue to see nice expansion in our gross margins, even on lower revenue. After excluding for one-time events, primarily severance and legal costs, adjusted EBITDA was about $1.5 million. Operating cash flow was $1.2 million, and we continue to have a strong balance sheet with $12.6 million in cash and no long-term debt.
This puts us in a strong position to invest where we think we'll see the biggest increase in shareholder value. I'll hand the call over to Dave to walk through our fiscal first quarter financial results in more detail, and then I'll come back with some comments and an outlook for the year ahead.
Dave? Thank you, Roy. Good morning, everyone.
I'll start with the first quarter results and then cover cash flow and the balance sheet. Total revenue for the first quarter of fiscal 2027 was $11.9 million, compared to $12.3 million in the first quarter of fiscal 2026. This increased platform revenue was more than offset by a decrease in transaction revenue. Our platform subscription revenue increased 3.7% to $5.3 million, compared to $5.1 million in the prior year quarter. The growth was driven by an increase in B2B platform ARR due to a mix of new logo generation and upsells and cross-sells into our existing customer base, partially offset by a decline in B2C ARR. We added 22 net new platform deployments in the quarter, bringing total deployments to 1,298 at quarter end.
We ended the quarter with $22.5 million in annual recurring revenue, up 5.7% year-over-year, which breaks down as approximately $16.5 million in B2B ARR and approximately $6 million in normalized ARR associated with Scite's B2C subscribers. B2B ARR grew $1.7 million, or 11.5%, versus the year-ago period. In the quarter, net B2B ARR increased approximately $257,000, while normalized B2C ARR declined approximately $299,000. B2B ARR included AI-related ARR of approximately $1.1 million, up 38% from the end of fiscal 2026. Please see yesterday afternoon's press release for how we define and use annual recurring revenue and other non-GAAP terms. Transaction revenue for the first quarter was approximately $6.6 million, compared to $7.2 million in the prior year quarter, a decline of approximately 8%, primarily reflecting lower paid order volume.
Our total active customer count for the quarter was 1,360 compared to 1,326 in the same period a year ago, with growth in academic customers more than offsetting a decline in corporate customers. Consolidated gross margin for the first quarter was 53.6%, a 300 basis point improvement over the first quarter of fiscal 2026. The increase is due to the ongoing revenue mix shift towards our higher margin platform business, which now represents 44.6% of our total revenue, along with higher transaction margins. Gross profit dollars grew 2.5% to $6.4 million despite the lower revenue base. The platform business recorded gross margin of 87% compared to 88.1% in the prior year quarter, reflecting slightly higher hosting and technology costs. Gross margin in our transactions business was 26.7% compared to 23.8% in the prior year quarter, a 280 basis point improvement.
The increase was primarily attributable to improved margins on our copyright content, reflecting favorable publisher mix and pricing. Total operating expenses in the quarter were $5.5 million compared to $5.3 million in the prior year quarter. Higher general and administrative expenses, primarily severance and legal costs, and higher technology and product development spending were partially offset by lower sales and marketing expense and a non-cash recovery of stock-based compensation resulting from forfeitures. Other expense for the quarter was $56,000 compared to $191,000 in the prior year quarter, primarily reflecting lower cash accreted interest on the Scite earnout liability. As a reminder, as of November 2nd, we have completed six of the eight quarterly Scite earnout payments. Net income for the quarter was $765,000 or $0.02 per diluted share compared to $749,000 or $0.02 per diluted share in the prior year quarter.
Adjusted EBITDA for the quarter was $1 million or an 8.6% margin compared to $1.5 million for the first quarter of last year. The decrease reflects higher general and administrative costs and increased technology investment, partially offset by higher gross profit and lower sales and marketing expenses. Turning to cash flow. Cash flow from operations for the first quarter of the fiscal year was approximately $1.2 million compared to approximately $1.1 million in the prior year quarter, helped by the timing of vendor payments. Turning to our balance sheet, cash and cash equivalents as of September 30th, 2026 were $12.6 million, essentially unchanged from June 30th, 2026, even after funding $1.2 million of cash Scite earnout payments during the quarter. There were no outstanding borrowings under our $500,000 revolving line of credit, and we have no long-term debt.
With a solid cash position and no debt, our balance sheet gives us the flexibility to complete the remaining Scite earnout payments in fiscal 2027, while at the same time continuing to invest in the business. I'll now turn the call over to Josh.
Josh? Thanks, Dave. Good morning, everyone.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
10 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
